Jason M. Hollar Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 4 months ago
Jason M. Hollar has an estimated net worth of at least $61.9 million*, as of Oct. 29, 2025. They own 200,000 shares of CAH stock. They have sold 216,777 shares of CAH stock since 2021, for an estimated $29.4 million.
Jason M. Hollar $CAH SEC Form 4 Insider Trading
Jason M. Hollar has filed a total of 7 insider trades in $CAH since 2021. Their most recent trade was a sale of 12,944 shares, made on Aug 20, 2025. Their largest trade was a sale of 94,735 shares, made on Aug 19, 2025. We estimate that they now own 200,000 shares of $CAH, worth an estimated $32.5 million.
Insider Trading at $CAH
There have been a total of 50 insider trades reported at $CAH since 2021, with 874 shares purchased and 807,512 shares sold. The most active insider traders in $CAH stock have been Ola M Snow, Jason M. Hollar, and Jessica L Mayer. The most recent trade was a sale of 2,328 shares reported by Aaron E Alt (Chief Financial Officer), made on Feb 18, 2026.
History of Insider Stock Trades by Jason M. Hollar
| Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
|---|---|---|---|---|
CAH
|
Sale | 12,944 | Aug 20, 2025 | Aug. 20, 2025, 4:12 p.m. |
|
CAH
|
Sale | 22,957 | Aug 20, 2025 | Aug. 20, 2025, 4:12 p.m. |
|
CAH
|
Sale | 6,313 | Aug 19, 2025 | Aug. 19, 2025, 7:19 p.m. |
|
CAH
|
Sale | 6,657 | Aug 19, 2025 | Aug. 19, 2025, 7:19 p.m. |
|
CAH
|
Sale | 94,735 | Aug 19, 2025 | Aug. 19, 2025, 7:19 p.m. |
|
CAH
|
Sale | 46,455 | Aug 19, 2024 | Aug. 19, 2024, 8:24 p.m. |
|
CAH
|
Sale | 26,716 | Aug 16, 2024 | Aug. 19, 2024, 8:24 p.m. |
$CAH Executives and Stock Owners with Insider Trades
-
Ola M Snow, Chief Human Resources Officer
-
Jason M. Hollar, Chief Executive Officer
-
Jessica L Mayer, Chief Legal/Compliance Officer
-
Stephen M Mason, CEO, GMPD Segment
-
Aaron E Alt, Chief Financial Officer
-
Michelle D. Greene, Chief Information Officer
-
Stephen M Mason, CEO, Medical Segment
-
Mary C. Scherer, Chief Accounting Officer
-
Deborah Weitzman, CEO, Pharmaceutical Segment
-
Deborah Weitzman, CEO, PSS Segment
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.